UK markets close in 5 hours 32 minutes

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
172.20+0.02 (+0.01%)
At close: 4:00PM EDT
173.00 +0.80 (0.46%)
Pre-market: 05:49AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close172.18
Open172.54
Bid0.00 x 800
Ask0.00 x 1200
Day's range171.84 - 172.98
52-week range133.65 - 173.65
Volume5,346,742
Avg. volume6,560,257
Market cap453.471B
Beta (5Y monthly)0.71
PE ratio (TTM)25.89
EPS (TTM)6.65
Earnings date19 Oct 2021
Forward dividend & yield4.24 (2.46%)
Ex-dividend date23 Aug 2021
1y target est187.39
  • Motley Fool

    How Novavax Could Shake Up the COVID Vaccine Market

    Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.

  • 3 Top Robinhood Stocks to Buy in August Instead of Dogecoin
    Motley Fool

    3 Top Robinhood Stocks to Buy in August Instead of Dogecoin

    In fact, the three companies I'll discuss today are in the top 50 of investing app Robinhood's most popular user holdings. Johnson & Johnson (NYSE: JNJ) will never again grow as quickly as Dogecoin, but it won't collapse as suddenly, either. The key reason that Johnson & Johnson is better than Dogecoin is that the company actually makes things -- specifically, a plethora of consumer healthcare and pharmaceutical products that people need on a daily basis to survive.

  • Motley Fool

    Will Moderna’s Tenure on the S&P 500 Index Be Short-Lived?

    Moderna (NASDAQ: MRNA) is now officially a member of the S&P 500. In this Motley Fool Live video recorded on July 21, 2021, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Moderna's tenure on the S&P 500 index will be short-lived. Let's go over to Moderna, which is now officially, I think today, a member of the S&P 500 Index.